Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-1638.28%
operating margin TTM
-1380.49%
revenue TTM
1.38 Million
revenue per share TTM
0.99$
valuation ratios | |
|---|---|
| pe ratio | -0.36 |
| peg ratio | 0.01 |
| price to book ratio | 0.77 |
| price to sales ratio | 6.72 |
| enterprise value multiple | -1.34 |
| price fair value | 0.77 |
profitability ratios | |
|---|---|
| gross profit margin | -94.3% |
| operating profit margin | -1380.49% |
| pretax profit margin | -1638.3% |
| net profit margin | -1638.28% |
| return on assets | -142.69% |
| return on equity | -197.53% |
| return on capital employed | -198.53% |
liquidity ratio | |
|---|---|
| current ratio | 2.42 |
| quick ratio | 2.42 |
| cash ratio | 1.59 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 92.92 |
| days of payables outstanding | 522.93 |
| cash conversion cycle | -430.01 |
| receivables turnover | 3.93 |
| payables turnover | 0.70 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.05 |
| debt equity ratio | 0.08 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.08 |
| interest coverage | -5.22 |
| cash flow to debt ratio | -24.87 |
cash flow ratios | |
|---|---|
| free cash flow per share | -6.10 |
| cash per share | 2.85 |
| operating cash flow per share | -6.10 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -24.87 |
| short term coverage ratios | -24.87 |
| capital expenditure coverage ratio | 0.00 |
Frequently Asked Questions
When was the last time Ensysce Biosciences, Inc. (NASDAQ:ENSC) reported earnings?
Ensysce Biosciences, Inc. (ENSC) published its most recent earnings results on 12-11-2024.
What is Ensysce Biosciences, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Ensysce Biosciences, Inc. (NASDAQ:ENSC)'s trailing twelve months ROE is -197.53%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Ensysce Biosciences, Inc. (ENSC) currently has a ROA of -142.69%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did ENSC's net profit margin stand at?
ENSC reported a profit margin of -1638.28% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is ENSC's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 2.42 in the most recent quarter. The quick ratio stood at 2.42, with a Debt/Eq ratio of 0.08.